Paid

Funding Opportunities

DOD Kidney Cancer Research Program

The FY18 Defense Appropriation provides $15 million to the Department of Defense Kidney Cancer Research Program to support the United States Medical Research Acquisition Activity. FY18 KCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website. Concept Award Letter of Intent due July 11 Idea Development Award... […]
In Brief

Prostate cancer expert Dorff joins COH

Tanya Dorff has joined City of Hope as an associate clinical professor in the Department of Medical Oncology, heading the genitourinary cancers program. She was previously at USC Keck School of Medicine, where she served as an associate professor of clinical medicine in the Department of Medicine.
In Brief

COH’s Djulbegovic directs Medicine and Comparative Effectiveness Research Program

Benjamin Djulbegovic, a professor and director of research in City of Hope's Department of Supportive Care Medicine, was named director of Evidence-based Medicine and Comparative Effectiveness Research, a new core program here at City of Hope created in response to an increasing realization that successful health care delivery and continuing improvement of patient outcomes depends on full integration of research, education and clinical practice.
The Trump administration “American Patients First” plan to reduce drug prices—
Guest Editorial

The Trump administration “American Patients First” plan to reduce drug prices—
Are American cancer patients first?

In May 2018, President Trump announced his plan to lower drug prices. “We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter. And it will start to take effect very soon,” he promised. The plan is outlined in a 40-page document by the U.S. Department of Health and Human Services titled “American Patients First—The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Cost.” (1)